Andreas Ströhle1, Jochen Gensichen, Katharina Domschke. 1. Department of Psychiatry and Psychotherapy, Campus Charité Mitte (CCM), Charité-Universitätsmedizin Berlin; Institute of General Practice, Faculty of Medicine, Ludwig-Maximilians-Universität München; Department of Psychiatry and Psychotherapy, University Hospital of Freiburg.
Abstract
BACKGROUND: Anxiety disorders are the most common type of mental illness in Europe, with a 12-month prevalence of 14% among persons aged 14 to 65. Their onset is usually in adolescence or early adulthood. The affected patients often develop further mental or somatic illnesses (sequential comorbidity). METHODS: This review is based on pertinent publications retrieved by a selective search in PubMed. RESULTS: The group of anxiety disorders includes generalized anxiety disorder (GAD), phobic disorders, panic disorders, and two disorders that are often restricted to childhood-separation anxiety and selective mutism. A comprehensive differential diag- nostic evaluation is essential, because anxiety can be a principal manifestation of other types of mental or somatic illness as well. Psychotherapy and treatment with psychoactive drugs are the therapeutic strategies of first choice. Of all types of psycho- therapy, cognitive behavioral therapy has the best documented efficacy. Modern antidepressants are the drugs of first choice for the treatment of panic disorders, agoraphobia, social phobia, and GAS; pregabalin is a further drug of first choice for GAS. CONCLUSION: In general, anxiety disorders can now be effectively treated. Patients should be informed of the therapeutic options and should be involved in treatment planning. Current research efforts are centered on individualized and therefore, it is hoped, even more effective treatment approaches than are available at present.
BACKGROUND:Anxiety disorders are the most common type of mental illness in Europe, with a 12-month prevalence of 14% among persons aged 14 to 65. Their onset is usually in adolescence or early adulthood. The affected patients often develop further mental or somatic illnesses (sequential comorbidity). METHODS: This review is based on pertinent publications retrieved by a selective search in PubMed. RESULTS: The group of anxiety disorders includes generalized anxiety disorder (GAD), phobic disorders, panic disorders, and two disorders that are often restricted to childhood-separation anxiety and selective mutism. A comprehensive differential diag- nostic evaluation is essential, because anxiety can be a principal manifestation of other types of mental or somatic illness as well. Psychotherapy and treatment with psychoactive drugs are the therapeutic strategies of first choice. Of all types of psycho- therapy, cognitive behavioral therapy has the best documented efficacy. Modern antidepressants are the drugs of first choice for the treatment of panic disorders, agoraphobia, social phobia, and GAS; pregabalin is a further drug of first choice for GAS. CONCLUSION: In general, anxiety disorders can now be effectively treated. Patients should be informed of the therapeutic options and should be involved in treatment planning. Current research efforts are centered on individualized and therefore, it is hoped, even more effective treatment approaches than are available at present.
Authors: Andrew T Gloster; Rainer Sonntag; Jürgen Hoyer; Andrea H Meyer; Simone Heinze; Andreas Ströhle; Georg Eifert; Hans-Ulrich Wittchen Journal: Psychother Psychosom Date: 2015-02-21 Impact factor: 17.659
Authors: Andrew T Gloster; Hans-Ulrich Wittchen; Franziska Einsle; Thomas Lang; Sylvia Helbig-Lang; Thomas Fydrich; Lydia Fehm; Alfons O Hamm; Jan Richter; Georg W Alpers; George W Alpers; Alexander L Gerlach; Andreas Ströhle; Tilo Kircher; Jürgen Deckert; Peter Zwanzger; Michael Höfler; Volker Arolt Journal: J Consult Clin Psychol Date: 2011-06
Authors: Falk Leichsenring; Simone Salzer; Manfred E Beutel; Stephan Herpertz; Wolfgang Hiller; Juergen Hoyer; Johannes Huesing; Peter Joraschky; Bjoern Nolting; Karin Poehlmann; Viktoria Ritter; Ulrich Stangier; Bernhard Strauss; Nina Stuhldreher; Susan Tefikow; Tobias Teismann; Ulrike Willutzki; Joerg Wiltink; Eric Leibing Journal: Am J Psychiatry Date: 2013-07 Impact factor: 18.112
Authors: Abdulrahman Ismaiel; Mihail Spinu; Daniel-Corneliu Leucuta; Stefan-Lucian Popa; Bogdan Augustin Chis; Mihaela Fadgyas Stanculete; Dan Mircea Olinic; Dan L Dumitrascu Journal: J Clin Med Date: 2022-04-28 Impact factor: 4.964
Authors: Aleksandar Makević; Aleksandra Ilić; Maja Pantović-Stefanović; Nemanja Murić; Nataša Djordjević; Vladimir Jurišić Journal: Int J Disaster Risk Reduct Date: 2022-06-03 Impact factor: 4.842
Authors: Marta Kopańska; Danuta Ochojska; Agnieszka Dejnowicz-Velitchkov; Agnieszka Banaś-Ząbczyk Journal: Int J Environ Res Public Health Date: 2022-02-21 Impact factor: 3.390
Authors: Ainsley Ryan Yan Bin Lee; Areeba Tariq; Grace Lau; Nicholas Wee Kiat Tok; Wilson Wai San Tam; Cyrus Su Hui Ho Journal: Nutrients Date: 2022-02-03 Impact factor: 5.717